Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity
Clinical trial NCT03287960 · COMPLETED
Trial details
- NCT number
- NCT03287960
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-30
- Primary completion
- 2020-09-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.